Abbasi Arjang DO - Commack, New York 11725

Abbasi Arjang DO is categorized under Doctors in Commack, NY .

Business Name: Abbasi Arjang DO
Contact Person: Arjang Abbasi
Address: 763 Larkfield Road # 201, Commack, New York 11725
Phone Number: (631) 462-2225
Website Address: lispine.com
Annual Revenue (USD): $500.000 to $999.999
Founding Year: 1997
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Silverstein David I MD - Commack, NY 11725
Andan Gordon Z MD - Commack, NY 11725
Cote Sharon MD - Commack, NY 11725
Daoud Marjorie T MD - Commack, NY 11725
Fox Joshua MD - Commack, NY 11725
Sondhi Rachna S MD - Commack, NY 11725
Daian Christina MD - Commack, NY 11725
Reina Grace E MD - Commack, NY 11725
Begum Shamim MD - Commack, NY 11725
Kramer Mitchell MD - Commack, NY 11725
Tsai Frank Y MD - Commack, NY 11725
Schwartz Jonathan K MD - Commack, NY 11725
Schulman Philip MD - Commack, NY 11725
Sclafani Lisa MD - Commack, NY 11725
Filippone Louis MD - Commack, NY 11725
Yavel Regina MD - Commack, NY 11725
Condon Edward MD - Commack, NY 11725
Basra Sushil K MD - Commack, NY 11725
Emami Elizabeth R MD - Commack, NY 11725
Nayak Bhaskar C MD - Commack, NY 11725

The company Abbasi Arjang DO provides B2C services in the form of Doctors from its single location in New York. 1 to 4 employees work for Abbasi Arjang DO, and the business now earns $500.000 to $999.999 per annum.

Abbasi Arjang DO was launched in 1997 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Abbasi Arjang DO, please call Arjang Abbasi with the phone number (631) 462-2225 or visit its single location at 763 Larkfield Road # 201 in Commack, New York 11725.

The location of the single location can also be found using the coordinates 40.83744,-73.31241. Read more details about this business on the webpage lispine.com or follow the company’s social media accounts, on Twitter and on Facebook.